Alawi, Sittie Aina U.

HRN: 27-39-42  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2025
CEFUROXIME 1.5GM (VIAL)
08/25/2025
08/26/2025
IV
1.5g
8hrs
LTCS With IUD
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines